Wessence Language Lab is a certified women-owned language service integrator with 30 years of expertise in Life Sciences and Healthcare. We bridge the gap between scientific rigor and multimedia agility, ensuring your message reaches physicians, regulators, and patients with total precision.
Our Strategic Focus:
Regulatory & Clinical: We specialize in eCTD filings, pharmacovigilance, and clinical trial protocols (Phases I-IV).
Digital Health & MedTech: Full translation for health apps, medical software, and eCOA/ePRO platforms.
Compliance-First Quality: Our workflows are audit-ready and compliant with GCP, HIPAA, FDA 21 CFR Part 11, and GDPR.
Language Engineering: We utilize AI-driven workflows optimized by mandatory final validation from human medical experts.
Why Partner With Us? We serve as your single point of contact for technical translation, content development, and audiovisual editing. By bridging Europe and the Americas, we support global expansion in English, Spanish, Portuguese, German, French, and Italian. As active members of Women in Localization, we deliver DEI-driven excellence that aligns with your corporate diversity goal.
As a US-incorporated solutions provider with our core operational headquarters in Latin America, we combine North American business standards with high-efficiency global workflows.
Medical field
Business services
Role / Function
Co-founder, Chief Business Development Officer
Wessence Language Lab
Service
Regulated-industry translation, localization, transcription, subtitling, and audiovisual services
Precision and compliance at scale, ensuring your message reaches regulators, clinicians, and patients clearly and safely worldwide.
Co-founder, Chief Business Development Officer at Wessence Language Lab
Buenos Aires, Argentina